Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system drugs including antidepressants, antipsychotics, and antiepileptic products... Show more
Industry PharmaceuticalsOther
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| CGTYX | 68.18 | 0.36 | +0.53% |
| Columbia Seligman Global Tech Inst3 | |||
| NBMRX | 24.44 | 0.09 | +0.37% |
| Neuberger Berman M/C Intrinsic Val R6 | |||
| CEVZX | 12.37 | 0.03 | +0.24% |
| Columbia Global Value Inst | |||
| WFPRX | 46.35 | 0.03 | +0.06% |
| Allspring Special Mid Cap Value R6 | |||
| SEEHX | 26.11 | -0.01 | -0.04% |
| Steward Values Enhanced Lg Cap R6 | |||
A.I.dvisor tells us that HLBBF and HYEX have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HLBBF and HYEX's prices will move in lockstep.
| Ticker / NAME | Correlation To HLBBF | 1D Price Change % | ||
|---|---|---|---|---|
| HLBBF | 100% | N/A | ||
| HYEX - HLBBF | 21% Poorly correlated | N/A | ||
| HLUBF - HLBBF | 18% Poorly correlated | N/A | ||
| HLN - HLBBF | 10% Poorly correlated | +1.61% | ||
| HLNCF - HLBBF | 8% Poorly correlated | +9.41% | ||
| STEK - HLBBF | 2% Poorly correlated | -11.52% | ||
More | ||||